Department of Radiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
PLoS One. 2013 Sep 12;8(9):e74530. doi: 10.1371/journal.pone.0074530. eCollection 2013.
Cerebral involvement is common in patients with systemic Lupus erythematosus (SLE) and is characterized by multiple clinical presentations, including cognitive disorders, headaches, and syncope. Several neuroimaging studies have demonstrated cerebral dysfunction during different tasks among SLE patients; however, there have been few studies designed to characterize network alterations or to identify clinical markers capable of reflecting the cerebral involvement in SLE patients. This study was designed to characterize the profile of the cerebral activation area and the functional connectivity of cognitive function in SLE patients by using a task-based and a resting state functional magnetic resonance imaging (fMRI) technique, and to determine whether or not any clinical biomarkers could serve as an indicator of cerebral involvement in this disease. The well-established cognitive function test (Paced Visual Serial Adding Test [PVSAT]) was used. Thirty SLE patients without neuropsychiatric symptoms and 25 age- and gender-matched healthy controls were examined using PVSAT task-based and resting state fMRI. Outside the scanner, the performance of patients and the healthy controls was similar. In the PVSAT task-based fMRI, patients presented significantly expanded areas of activation, and the activated areas exhibited significantly higher functional connectivity strength in patients in the resting state. A positive correlation existed between individual connectivity strength and disease activity scoring. No correlation with cerebral involvement existed for serum markers, such as C3, C4, and anti-dsDNA. Thus, our findings may shed new light on the pathologic mechanism underlying neuropsychiatric SLE, and suggests that disease activity may be a potential effective biomarker reflecting cerebral involvement in SLE.
脑损伤在系统性红斑狼疮(SLE)患者中很常见,其特征是多种临床表现,包括认知障碍、头痛和晕厥。几项神经影像学研究表明 SLE 患者在执行不同任务时存在大脑功能障碍;然而,很少有研究旨在描述网络改变或识别能够反映 SLE 患者大脑受累的临床标志物。本研究旨在通过使用基于任务和静息状态功能磁共振成像(fMRI)技术来描述 SLE 患者大脑激活区和认知功能的功能连接特征,并确定是否有任何临床生物标志物可以作为该病脑受累的指标。采用了成熟的认知功能测试(Paced Visual Serial Adding Test [PVSAT])。使用 PVSAT 基于任务和静息状态 fMRI 检查了 30 名无神经精神症状的 SLE 患者和 25 名年龄和性别匹配的健康对照者。在扫描仪外,患者和健康对照组的表现相似。在 PVSAT 基于任务的 fMRI 中,患者表现出明显扩大的激活区,而在静息状态下,患者的激活区表现出明显更高的功能连接强度。个体连接强度与疾病活动评分呈正相关。血清标志物如 C3、C4 和抗 dsDNA 与脑受累无相关性。因此,我们的研究结果可能为神经精神性 SLE 的病理机制提供新的认识,并表明疾病活动可能是反映 SLE 患者大脑受累的潜在有效生物标志物。